In this issue of Blood, Gibson et al provide provocative information suggesting that use of otherwise normal stem cell donors with clonal hematopoiesis of indeterminate potential (CHIP) results in impaired hematopoietic recovery following allogeneic hematopoietic stem cell transplantation (HSCT).1
CITATION STYLE
Appelbaum, F. R., & Radich, J. P. (2017, July 6). CHIPs and engraftment dips. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-05-782664
Mendeley helps you to discover research relevant for your work.